These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7103786

  • 1. Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease.
    Weiner WJ, Nausieda PA.
    Arch Neurol; 1982 Jul; 39(7):451-2. PubMed ID: 7103786
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E, Martí MJ.
    Adv Neurol; 1988 Jul; 49():73-84. PubMed ID: 3278555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.
    Sage JI, Sonsalla PK, McHale DM, Heikkila RE, Duvoisin RC.
    Adv Neurol; 1990 Jul; 53():383-6. PubMed ID: 2122646
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel.
    Solla P, Cannas A, Marrosu MG, Marrosu F.
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1383-4. PubMed ID: 26453388
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
    Lombardo L, De la Garza R.
    Arch Invest Med (Mex); 1977 Nov; 8(2):123-8. PubMed ID: 907417
    [Abstract] [Full Text] [Related]

  • 12. Levodopa-Carbidopa-Related Rash in Parkinson's Disease: A Case Series.
    Anang JBM.
    Can J Neurol Sci; 2018 Sep; 45(5):588-589. PubMed ID: 30033887
    [No Abstract] [Full Text] [Related]

  • 13. Increased dosage of carbidopa in patients with Parkinson's disease receiving low doses of levodopa. A pilot study.
    Hoehn MM.
    Arch Neurol; 1980 Mar; 37(3):146-9. PubMed ID: 7356419
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy.
    Weiner WJ, Nausieda PA, Glantz RH.
    Neurology; 1981 Dec; 31(12):1555-6. PubMed ID: 6118844
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Zimmerman TR, Sage JI, Lang AE, Mark MH.
    Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
    [Abstract] [Full Text] [Related]

  • 19. Blepharospasm--oromandibular dystonia (Meige's syndrome) misdiagnosed as secondary hemifacial spasm.
    Gottlieb JS, May M.
    Am J Otol; 1984 Jan; 5(3):206-10. PubMed ID: 6720874
    [Abstract] [Full Text] [Related]

  • 20. An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off.
    Koller W, Guarnieri M, Hubble J, Rabinowicz AL, Silver D.
    J Neural Transm (Vienna); 2005 Feb; 112(2):221-30. PubMed ID: 15503197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.